Figure 4From: Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients Associations between imaging and tissue measures. (a) Baseline FDG SUV and baseline Ki-67. (b) Percent change in FDG SUV and percentage change in Ki-67. (c) Percent change in FDG SUV and follow-up Ki-67.Back to article page